Serveur d'exploration Chloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Mechanism of cyclosporin A-induced inhibition of prostacyclin synthesis by macrophages

Identifieur interne : 003482 ( Main/Exploration ); précédent : 003481; suivant : 003483

Mechanism of cyclosporin A-induced inhibition of prostacyclin synthesis by macrophages

Auteurs : T.-P. D. Fan ; G. P. Lewis

Source :

RBID : ISTEX:CB30EED0C8DAA24D12119EB0E2FB621DAB666221

English descriptors

Abstract

Abstract: In vitro studies of PG production over a 24 h period by adherent rat peritoneal macrophages activated by serum-opsonized zymosan revealed that CSA (0.3 – 10 μg/ml) caused a dose-related inhibition of PGI2 (assayed as 6-oxo-PGF1α) formation. Indomethacin (IND, 0.01 – 10 μg/ml) and dexamethasone (DEX, 0.01 – 10 μg/ml) also inhibited the PG production in a dose-related manner. When arachidonic acid (10 μg/ml) was added together with the inhibitors, there was no change in the level of PGI2 produced by IND-treated cells whilst the PGI2 levels of DEX- and CSA-treated cells were elevated to the control level. Therefore CSA like DEX does not inhibit cyclo-oxygenase activity. However unlike DEX, CSA (1 – 30 μg/ml) caused inhibition of phospholipase A2 (PLA2) activity when assayed on the hydrolysis of a synthetic substrate by pancreatic PLA2 in a cell-free system. The direct inhibition of PLA2 might well be a manifestation of the fundamental activity of CSA on immunocompetent cells.

Url:
DOI: 10.1016/0090-6980(85)90004-8


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title>Mechanism of cyclosporin A-induced inhibition of prostacyclin synthesis by macrophages</title>
<author>
<name sortKey="Fan, T P D" sort="Fan, T P D" uniqKey="Fan T" first="T.-P. D." last="Fan">T.-P. D. Fan</name>
</author>
<author>
<name sortKey="Lewis, G P" sort="Lewis, G P" uniqKey="Lewis G" first="G. P." last="Lewis">G. P. Lewis</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:CB30EED0C8DAA24D12119EB0E2FB621DAB666221</idno>
<date when="1985" year="1985">1985</date>
<idno type="doi">10.1016/0090-6980(85)90004-8</idno>
<idno type="url">https://api.istex.fr/ark:/67375/6H6-Z52LGJWW-R/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">002760</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">002760</idno>
<idno type="wicri:Area/Istex/Curation">002760</idno>
<idno type="wicri:Area/Istex/Checkpoint">002240</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">002240</idno>
<idno type="wicri:doubleKey">0090-6980:1985:Fan T:mechanism:of:cyclosporin</idno>
<idno type="wicri:Area/Main/Merge">003556</idno>
<idno type="wicri:Area/Main/Curation">003482</idno>
<idno type="wicri:Area/Main/Exploration">003482</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a">Mechanism of cyclosporin A-induced inhibition of prostacyclin synthesis by macrophages</title>
<author>
<name sortKey="Fan, T P D" sort="Fan, T P D" uniqKey="Fan T" first="T.-P. D." last="Fan">T.-P. D. Fan</name>
<affiliation>
<wicri:noCountry code="no comma">Department of Pharmacology Institute of Basic Medical Sciences Royal College of Surgeons of England London WC2A 3PN UK</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Lewis, G P" sort="Lewis, G P" uniqKey="Lewis G" first="G. P." last="Lewis">G. P. Lewis</name>
<affiliation>
<wicri:noCountry code="no comma">Department of Pharmacology Institute of Basic Medical Sciences Royal College of Surgeons of England London WC2A 3PN UK</wicri:noCountry>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Prostaglandins</title>
<title level="j" type="abbrev">PROOLD</title>
<idno type="ISSN">0090-6980</idno>
<imprint>
<publisher>ELSEVIER</publisher>
<date type="published" when="1985">1985</date>
<biblScope unit="volume">30</biblScope>
<biblScope unit="issue">5</biblScope>
<biblScope unit="page" from="735">735</biblScope>
<biblScope unit="page" to="747">747</biblScope>
</imprint>
<idno type="ISSN">0090-6980</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0090-6980</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="Teeft" xml:lang="en">
<term>Absolute ethanol</term>
<term>Arachidonic</term>
<term>Arachidonic acid</term>
<term>Basal level</term>
<term>Culture medium</term>
<term>Cyclosporin</term>
<term>Dexamethasone</term>
<term>Drug concentration</term>
<term>Exogenous arachidonic acid</term>
<term>Glucocorticoid</term>
<term>Graft rejection</term>
<term>Increase membrane</term>
<term>Indomethacin</term>
<term>Macrophage</term>
<term>Membrane phospholipids</term>
<term>Mononuclear cells</term>
<term>November</term>
<term>Peritoneal</term>
<term>Peritoneal macrophages</term>
<term>Phospholipase</term>
<term>Present experiments</term>
<term>Present investigation</term>
<term>Present study</term>
<term>Prostaglandin</term>
<term>Prostaglandin formation</term>
<term>Prostanoid</term>
<term>Prostanoid production</term>
<term>Prostanoid synthesis</term>
<term>Separate experiments</term>
<term>Serumopsonized zymosan</term>
<term>Skin grafts</term>
<term>Zymosan</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Abstract: In vitro studies of PG production over a 24 h period by adherent rat peritoneal macrophages activated by serum-opsonized zymosan revealed that CSA (0.3 – 10 μg/ml) caused a dose-related inhibition of PGI2 (assayed as 6-oxo-PGF1α) formation. Indomethacin (IND, 0.01 – 10 μg/ml) and dexamethasone (DEX, 0.01 – 10 μg/ml) also inhibited the PG production in a dose-related manner. When arachidonic acid (10 μg/ml) was added together with the inhibitors, there was no change in the level of PGI2 produced by IND-treated cells whilst the PGI2 levels of DEX- and CSA-treated cells were elevated to the control level. Therefore CSA like DEX does not inhibit cyclo-oxygenase activity. However unlike DEX, CSA (1 – 30 μg/ml) caused inhibition of phospholipase A2 (PLA2) activity when assayed on the hydrolysis of a synthetic substrate by pancreatic PLA2 in a cell-free system. The direct inhibition of PLA2 might well be a manifestation of the fundamental activity of CSA on immunocompetent cells.</div>
</front>
</TEI>
<affiliations>
<list></list>
<tree>
<noCountry>
<name sortKey="Fan, T P D" sort="Fan, T P D" uniqKey="Fan T" first="T.-P. D." last="Fan">T.-P. D. Fan</name>
<name sortKey="Lewis, G P" sort="Lewis, G P" uniqKey="Lewis G" first="G. P." last="Lewis">G. P. Lewis</name>
</noCountry>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003482 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003482 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:CB30EED0C8DAA24D12119EB0E2FB621DAB666221
   |texte=   Mechanism of cyclosporin A-induced inhibition of prostacyclin synthesis by macrophages
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021